- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Emyria Ltd (EMD)
Emyria Ltd stock price live, this page displays ASX EMD stock exchange data. View the EMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Emyria Ltd real time stock price chart below.
What Is the Emyria Ltd Stock Price Today?
The Emyria Ltd stock price today is 0.05.
What Is the Stock Symbol for Emyria Ltd?
The stock symbol for Emyria Ltd is "EMD."
What Stock Exchange Does Emyria Ltd Trade On?
Emyria Ltd is listed and trades on the Sydney stock exchange.
Is Emyria Ltd a Good Stock to Buy?
Determining whether Emyria Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMD quote. (ISIN: AU0000073645)
What Is the Emyria Ltd Stock Price Today?
The Emyria Ltd stock price today is 0.05.
What Is the Stock Symbol for Emyria Ltd?
The stock symbol for Emyria Ltd is "EMD."
What Stock Exchange Does Emyria Ltd Trade On?
Emyria Ltd is listed and trades on the Sydney stock exchange.
Is Emyria Ltd a Good Stock to Buy?
Determining whether Emyria Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMD quote. (ISIN: AU0000073645)
Sydney
Currency in AUD
0.05
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.05
0.05
52 wk Range
0.04
0.08
EMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.050.05
52 wk Range
0.040.08
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
EMD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Emyria Ltd Earnings Call Summary for H2/2026
- Emyria reported FY 2026 revenue of AUD 4M, up 208% YoY, as clinic network expanded from one to five sites and patient volume rose to 138.
- Perth clinic achieved break-even profitability, validating unit economics; management expects new clinics to reach profitability within 9-12 months.
- Company scaled operational capacity to 18 beds and 145 trained clinicians; Sydney clinic opening planned for early 2027 to expand treatment access.
- Shares fell 2-4% post-results as investors await group-level profitability despite strong revenue growth and clinic expansion momentum.
- Management targeting capital-light hospital partnerships and broader insurer reimbursement; Empax program to support global sponsors entering psychedelic therapy.
Last Updated: 2026-09-07, 10:12 p/m
Read Full TranscriptEarnings
Latest Release
Aug 31, 2026
EPS / Forecast
-- / --
Revenue / Forecast
2.5M / --
Compare EMD to Peers and Sector
Metrics to compare | EMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.6x | −6.7x | −0.4x | |
PEG Ratio | 0.36 | −0.09 | 0.00 | |
Price/Book | 4.6x | 2.7x | 2.6x | |
Price / LTM Sales | 9.9x | 7.3x | 3.0x | |
Upside (Analyst Target) | - | 164.2% | 55.0% | |
Fair Value Upside | Unlock | 18.8% | 7.6% | Unlock |
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-RX9) and proprietary MDMA analogues, as well as provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the expand Emyria’s MDMA analogue drug development program. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Subiaco, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Emyria (EMD) Stock Price Today?
The Emyria stock price today is 0.05 AUD.
What Stock Exchange Does Emyria Trade On?
Emyria is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Emyria?
The stock symbol for Emyria is "EMD."
What Is the Emyria Market Cap?
As of today, Emyria market cap is 40.33M AUD.
What Is Emyria's Earnings Per Share (TTM)?
The Emyria EPS (TTM) is -0.01.
When Is the Next Emyria Earnings Date?
Emyria will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is EMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Emyria Stock Split?
Emyria has split 0 times.
What is the current trading status of Emyria (EMD)?
As of Sep 18, 2026, Emyria (EMD) is trading at a price of 0.05 AUD, with a previous close of 0.05 AUD. The stock has fluctuated within a day range of 0.05 AUD to 0.05 AUD, while its 52-week range spans from 0.04 AUD to 0.08 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.